Efficacy of Helicobacter pylori eradication therapy in chronic liver disease

Digestive and Liver Disease

Volumn 41, Issue 2, 2009, Pages 134-140

  Jung, S W ^a   Lee, S W ^a   Hyun, J J ^a   Kim, D I ^a   Koo, J S ^a   Yim, H J ^a   Park, J J ^a   Lee, H S ^a   Chun, H J ^a   Um, S H ^a   Choi, J H ^a   Kim, C D ^a   Ryu, H S ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Chronic liver disease; Eradication rate; Helicobacter pylori

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; PROTON PUMP INHIBITOR;

ABDOMINAL DISCOMFORT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BITTER TASTE; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; ERADICATION THERAPY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LIVER CIRRHOSIS; LOOSE FECES; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; SIDE EFFECT; TREATMENT DURATION; UREA BREATH TEST;

ADULT; ALANINE TRANSAMINASE; AMOXICILLIN; ANTI-BACTERIAL AGENTS; BREATH TESTS; CLARITHROMYCIN; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ENDOSCOPY, DIGESTIVE SYSTEM; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HEPATITIS, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PEPTIC ULCER; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 58149176103     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2008.03.005     Document Type: Article

References (29)

1. Kirk A.P., Dooley J.S., and Hunt R.H. Peptic ulceration in patients with chronic liver disease. Dig Dis Sci 25 (1980) 756-760
2. Rabinovitz M., Yoo Y.K., Schade R.R., Dindzans V.J., Van Thiel D.H., and Gavaler J.S. Prevalence of endoscopic findings in 510 consecutive individuals with cirrhosis evaluated prospectively. Dig Dis Sci 35 (1990) 705-710
3. Chen L.S., Lin H.C., Hwang S.J., Lee F.Y., Hou M.C., and Lee S.D. Prevalence of gastric ulcer in cirrhotic patients and its relation to portal hypertension. J Gastroenterol Hepatol 11 (1996) 59-64
4. Siringo S., Burroughs A.K., Bolondi L., Muia A., Di Febo G., Miglioli M., et al. Peptic ulcer and its course in cirrhosis: an endoscopic and clinical prospective study. J Hepatol 22 (1995) 633-641
5. Tsai C.J. Helicobacter pylori infection and peptic ulcer disease in cirrhosis. Dig Dis Sci 43 (1998) 1219-1225
6. Zullo A., Hassan C., and Morini S. Helicobacter pylori infection in patients with liver cirrhosis: facts and fictions. Dig Liver Dis 35 (2003) 197-205
7. Brown L.M. Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev 22 (2000) 283-297
8. Hopkins R.J., Girardi L.S., and Turney E.A. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 110 (1996) 1244-1252
9. Calvet X., Navarro M., Gil M., Mas P., Rivero E., Sanfeliu I., et al. Seroprevalence and epidemiology of Helicobacter pylori infection in patients with cirrhosis. J Hepatol 26 (1997) 1249-1254
10. Wu C.S., Lin C.Y., and Liaw Y.F. Helicobacter pylori in cirrhotic patients with peptic ulcer disease: a prospective, case controlled study. Gastrointest Endosc 42 (1995) 424-427
11. Chen J.J., Changchien C.S., Tai D.I., Chiou S.S., Lee C.M., and Kuo C.H. Role of Helicobacter pylori in cirrhotic patients with peptic ulcer. A serological study. Dig Dis Sci 39 (1994) 1565-1568
12. Pellicano R., Leone N., Berrutti M., Cutufia M.A., Fiorentino M., Rizzetto M., et al. Helicobacter pylori seroprevalence in hepatitis C virus positive patients with cirrhosis. J Hepatol 33 (2000) 648-650
13. Auroux J., Lamarque D., Roudot-Thoraval F., Deforges L., Chaumette M.T., Richardet J.P., et al. Gastroduodenal ulcer and erosions are related to portal hypertensive gastropathy and recent alcohol intake in cirrhotic patients. Dig Dis Sci 48 (2003) 1118-1123
14. Di Mario F., Gottardello L., Germana B., Dotto P., Grassi S.A., Vianello F., et al. Peptic ulcer in cirrhotic patients: a short- and long-term study with antisecretory drugs. Ital J Gastroenterol 24 (1992) 122-125
15. Sarfeh I.J., Tarnawski A., Malki A., Mason G.R., Mach T., and Ivey K.J. Portal hypertension and gastric mucosal injury in rats. Effects of alcohol. Gastroenterology 84 (1983) 987-993
16. Sarfeh I.J., Tarnawski A., Maeda R., Raymont K., Mason G.R., and Ivey K.J. The gastric mucosa in portal hypertension: effects of topical bile acid. Scand J Gastroenterol Suppl 92 (1984) 189-194
17. Lo W.C., Lin H.J., Wang K., Lee F.Y., Perng C.L., Lin H.C., et al. Gastric secretion in Chinese patients with cirrhosis. J Clin Gastroenterol 23 (1996) 256-260
18. Kameyama J., Suzuki Y., Suzuki A., Hoshikawa T., Yasaku Y., Yoshimur N., et al. Gastric mucus secretion in portal hypertension. J Gastroenterol Hepatol 4 Suppl 1 (1989) 126S-128S
19. Calvet X., Navarro M., Gil M., Lafont A., Sanfeliu I., Brullet E., et al. Epidemiology of peptic ulcer disease in cirrhotic patients: role of Helicobacter pylori infection. Am J Gastroenterol 93 (1998) 2501-2507
20. Vergara M., Calvet X., and Roque M. Helicobacter pylori is a risk factor for peptic ulcer disease in cirrhotic patients. A meta-analysis. Eur J Gastroenterol Hepatol 14 (2002) 717-722
21. Dore M.P., Mura D., Deledda S., Maragkoudakis E., Pironti A., and Realdi G. Active peptic ulcer disease in patients with hepatitis C virus-related cirrhosis: the role of Helicobacter pylori infection and portal hypertensive gastropathy. Can J Gastroenterol 18 (2004) 521-524
22. Lo G.H., Yu H.C., Chan Y.C., Chen W.C., Hsu P.I., Lin C.K., et al. The effects of eradication of Helicobacter pylori on the recurrence of duodenal ulcers in patients with cirrhosis. Gastrointest Endosc 62 (2005) 350-356
23. Saad R.J., and Chey W.D. Peptic ulcer disease in patients with chronic liver disease: looking beyond bugs and drugs. Gastrointest Endosc 62 (2005) 357-359
24. Malfertheiner P., Megraud F., O'Morain C., Hungin A.P., Jones R., Axon A., et al. Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 consensus report. Aliment Pharmacol Ther 16 (2002) 167-180
25. Park I.S., Lee Y.C., Park H.J., Kim T.I., Lee S.I., Kim H., et al. Helicobacter pylori infection in Korea. Yonsei Med J 42 (2001) 457-470
26. Farrell G., Baird-Lambert J., Cvejic M., and Buchanan N. Disposition and metabolism of metronidazole in patients with liver failure. Hepatology 4 (1984) 722-726
27. Azuma T., Ito S., Suto H., Ito Y., Miyaji H., Yamazaki Y., et al. Pharmacokinetics of clarithromycin in Helicobacter pylori eradication therapy in patients with liver cirrhosis. Aliment Pharmacol Ther 14 Suppl 1 (2000) S216-S222
28. Gustavson L.E., Kaiser J.F., Edmonds A.L., Locke C.S., DeBartolo M.L., and Schneck D.W. Effect of omeprazole on concentrations of clarithromycin in plasma and gastric tissue at steady state. Antimicrob Agents Chemother 39 (1995) 2078-2083
29. Reichling J.J., and Kaplan M.M. Clinical use of serum enzymes in liver disease. Dig Dis Sci 33 (1988) 1601-1614